Compare Eli Lilly And Co (LLY) vs Monolithic Power Systems Inc (MPWR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Monolithic Power Systems Inc — how do they compare? Eli Lilly And Co trades at $1,179.27 (market cap $1.04T), while Monolithic Power Systems Inc trades at $1,386.29 (market cap $67.32B). The key difference: Eli Lilly And Co is far larger — about 15.4× Monolithic Power Systems Inc's market cap, and Eli Lilly And Co pays the higher dividend (0.59%). Which is the better fit depends on your goals — on Pluang, investors hold Eli Lilly And Co for 93 Days and Monolithic Power Systems Inc for 25 Days on average.
| LLY | MPWR | |
|---|---|---|
Market Cap | $1.04T | $67.32B |
Volume | 3,064,878 | 826,960 |
Sector | Health | Technology |
52-Week High | $1.28K | $1.69K |
52-Week Low | $799.57 | $856.96 |
Typical Hold Time | 93 Days | 25 Days |
Enterprise Value | $1.09T | $65.92B |
Dividend Yield | 0.59% | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,169.93, down 1.58% on the day, but maintains strong bullish momentum with consistent earnings beats and robust revenue growth. The company's weight-loss drug portfolio continues to drive exceptional performance, with Q2 2026 EPS of $8.38 beating expectations by 31%. Technical indicators show bullish moving averages while fundamentals reveal impressive 83.4% gross margins and 102.44% ROE. Recent clinical trial successes for next-generation obesity treatments position Lilly for continued market leadership.
LLY presents a compelling growth story with dominant positioning in the expanding obesity/diabetes market, though elevated valuations (P/E 39.26) and regulatory risks require monitoring. Analyst consensus remains strongly bullish with $1,350 price target representing 15% upside. The primary investment thesis centers on pipeline execution and market expansion opportunities, balanced against competitive pressures and valuation concerns.
MPWR trades at $1,369.80, down 3.94% today but maintains strong technical momentum with bullish moving averages. The company demonstrates robust fundamentals with 24.5% net income margin and consistent earnings beats, supported by AI infrastructure demand. Recent news highlights CEO stock sales and a strategic manufacturing partnership with GlobalFoundries to expand capacity.
Outlook remains positive with 88% analyst buy ratings and $1,830 consensus price target, though premium valuations (P/E 83.6) and insider selling present near-term risks. Revenue growth to $3.3B in 2026 and expanding AI market opportunities support long-term potential, but investors should monitor execution risks and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Monolithic Power Systems Inc
Monolithic Power Systems, Inc. is a global leader in high-performance, analog, and mixed-signal semiconductors. The company specializes in power management solutions, providing integrated circuits (ICs) for a wide range of applications, including computing, automotive, industrial, and communications. MPWR's proprietary process technology is designed to deliver highly energy-efficient and compact power solutions, positioning the company as a key supplier for the next generation of electronic devices.
Read more on MPWR →
